/Bristol-Myers%20Squibb%20Co_%20logo%20on%20building-by%20tatu%20Campelo%20via%20iStock.jpg)
Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) is one of the leading biopharmaceutical companies focused on developing treatments for diseases like cancer, inflammatory, immunologic, cardiovascular, and fibrotic diseases. With a market cap of $96.5 billion, Bristol-Myers’ operations span various countries in the Americas, Europe, and the Indo-Pacific.
Companies worth $10 billion or more are generally described as “large-cap stocks.” BMY fits this bill perfectly. Given the company’s extensive operations and dominance in the pharma space, its valuation above this mark is unsurprising.